Authors: BALDWIN ET SARVER RW BRYANT GL CURRY KA FAIRBANKS MB FINZEL BC GARLICK RL HEINRIKSON RL HORTON NC KELLEY LLC MILDNER AM MOON JB MOTT JE MUTCHLER VT TOMICH CSC WATENPAUGH KD WILEY VH

Citation: Et. Baldwin et al., CATION-BINDING TO THE INTEGRIN CD11B I-DOMAIN AND ACTIVATION MODEL ASSESSMENT, Structure, 6(7), 1998, pp. 923-935

Authors: EPPS DE YEM AW MCGEE JM TOMICH CSC CURRY KA CHOSAY JG DEIBEL MR

Citation: De. Epps et al., FLUORESCENCE AND SITE-DIRECTED MUTAGENESIS STUDIES OF INTERLEUKIN-1-BETA, Cytokine, 9(3), 1997, pp. 149-156

Authors: THAISRIVONGS S WATENPAUGH KD HOWE WJ TOMICH PK DOLAK LA CHONG KT TOMICH CSC TOMASSELLI AG TURNER SR STROHBACH JW MULICHAK AM JANAKIRAMAN MN MOON JB LYNN JC HORNG MM HINSHAW RR CURRY KA ROTHROCK DJ

Citation: S. Thaisrivongs et al., STRUCTURE-BASED DESIGN OF NOVEL HIV PROTEASE INHIBITORS - CARBOXAMIDE-CONTAINING 4-HYDROXYCOUMARINS AND 4-HYDROXY-2-PYRONES AS POTENT NONPEPTIDIC INHIBITORS, Journal of medicinal chemistry, 38(18), 1995, pp. 3624-3637

Authors: MULICHAK AM HUI JO TOMASSELLI AG HEINRIKSON RL CURRY KA TOMICH CS THAISRIVONGS S SAWYER TK WATENPAUGH KD

Citation: Am. Mulichak et al., THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 WITH 2 SYNTHETIC PEPTIDIC TRANSITION-STATE ANALOG INHIBITORS, The Journal of biological chemistry, 268(18), 1993, pp. 3103-3109